Erratum: Laser-supported CD133+ cell therapy in patients with ischemic cardiomyopathy: Initial results from a prospective Phase I multicenter trial (PLoS ONE (2014) 9:7 DOI:10.1371/journal.pone.0101449);Laser-supported CD133+ cell therapy in patients with ischemic cardiomyopathy: Initial results from a prospective phase I multicenter trial

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Assmann, Alexander ^a,b,c   Heke, Michael ^a   Kröpil, Patric ^a   Ptok, Lena ^a   Hafner, Dieter ^a   Ohmann, Christian ^a   Martens, Andreas ^d   Karluß, Antje ^f   Emmert, Maximilian Y ^f   Kutschka, Ingo ^d   Sievers, Hans Hinrich ^e   Klein, Hans Michael ^a  

^a Department of Orthopedic Surgery   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE; POTASSIUM; TROPONIN T; CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD EXAMINATION; BONE MARROW CELL; CANADIAN CARDIOVASCULAR SOCIETY; CARDIOVASCULAR MAGNETIC RESONANCE; CELL COUNT; CELL ISOLATION; CELL TRANSPLANTATION; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENDOGENOUS LASER INDUCED VENTRICULAR ENHANCEMENT; FEASIBILITY STUDY; FEMALE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART PERFUSION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC CARDIOMYOPATHY; LACTATE DEHYDROGENASE BLOOD LEVEL; LOW LEVEL LASER THERAPY; MALE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PHASE 1 CLINICAL TRIAL; PHYSICAL EXAMINATION; POTASSIUM BLOOD LEVEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SAFETY; SCAR; SCORING SYSTEM; SEPTIC SHOCK; SUDDEN CARDIAC DEATH; CARDIOMYOPATHY; CELL SEPARATION; CLINICAL TRIAL; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; METABOLISM; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY;

AGED; ANTIGENS, CD; BONE MARROW CELLS; CARDIOMYOPATHIES; CELL SEPARATION; CELL TRANSPLANTATION; CORONARY ARTERY BYPASS; FEASIBILITY STUDIES; FEMALE; GLYCOPROTEINS; HUMANS; LASER THERAPY; MALE; MYOCARDIAL ISCHEMIA; PEPTIDES; SAFETY; VENTRICULAR FUNCTION, LEFT;

EID: 84904353803     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107082     Document Type: Erratum

References (34)

1. Sanganalmath SK, Bolli R (2013) Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 113: 810-834.
2. Klein HM, Ghodsizad A, Marktanner R, Poll L, Voelkel T, et al. (2007) Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg Forum 10: E66-E69.
3. Menasché P (2008) Cardiac cell therapy trials: chronic myocardial infarction and congestive heart failure. J Cardiovasc Transl Res 1: 201-206.
4. Manginas A, Goussetis E, Koutelou M, Karatasakis G, Peristeri I, et al. (2007) Pilot study to evaluate the safety and feasibility of intracoronary CD133 (+) and CD133(2) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction. Catheter Cardiovasc Interv 69: 773-781. (Pubitemid 46867476)
5. Strauer BE, Steinhoff G (2011) 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol 58: 1095-1104.
6. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, et al. (2012) Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 126: 551-568.
7. Li W, Tanaka K, Chiba Y, Kimura T, Morioka K, et al. (2003) Role of MMPs and plasminogen activators in angiogenesis after transmyocardial laser revascularization in dogs. Am J Physiol Heart Circ Physiol 284: H23-H30. (Pubitemid 36076266)
8. Klein HM, Ghodsizad A, Borowski A, Saleh A, Draganov J, et al. (2004) Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases. Heart Surg Forum 7: E416-E419.
9. Klein HM, Assmann A, Lichtenberg A, Heke M (2010) Intraoperative CD133+ cell transplantation during coronary artery bypass grafting in ischemic cardiomyopathy. MMCTS (0809):3947.
10. Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, et al. (2007) Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 133: 717-725.
11. Babin-Ebell J, Sievers HH, Charitos EI, Klein HM, Jung F, et al. (2010) Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell transplantation in patients with intractable ischemic heart disease ineligible for conventional revascularization: preliminary results in a highly selected small patient cohort. Thorac Cardiovasc Surg 58: 11-16.
12. Hughes GC, Kypson AP, Annex BH, Yin B, St Louis JD, et al. (2000) Induction of angiogenesis after TMR: a comparison of holmium: YAG, CO2, and excimer lasers. Ann Thorac Surg 70: 504-509.
13. Hughes GC, Biswas SS, Yin B, Baklanov DV, Annex BH, et al. (2002) A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. J Am Coll Cardiol 39: 1220-1228. (Pubitemid 34267429)
14. Fuchs S, Baffour R, Vodovotz Y, Shou M, Stabile E, et al. (2002) Laser myocardial revascularization modulates expression of angiogenic, neuronal, and inflammatory cytokines in a porcine model of chronic myocardial ischemia. J Card Surg 17: 413-424. (Pubitemid 36250328)
15. Patel AN, Spadaccio C, Kuzman M, Park E, Fischer DW, et al. (2007) Improved cell survival in infarcted myocardium using a novel combination transmyocardial laser and cell delivery system. Cell Transplant 16: 899-905. (Pubitemid 351448607)
16. Schneider J, Diegeler A, Krakor R, Walther T, Kluge R, et al. (2001) Transmyocardial laser revascularization with the holmium:YAG laser: loss of symptomatic improvement after 2 years. Eur J Cardiothorac Surg 19: 164-169. (Pubitemid 32143693)
17. Horvath KA (2008) Transmyocardial laser revascularization. J Card Surg 23: 266-276.
18. Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, et al. (2011) Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res 109: 428-436.
19. Reyes G, Allen KB, Aguado B, Duarte J (2009) Bone marrow laser revascularisation for treating refractory angina due to diffuse coronary heart disease. Eur J Cardiothorac Surg 36: 192-194.
20. Strauer BE, Yousef M, Schannwell CM (2010) The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur J Heart Fail 12: 721-729
21. Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U, et al. (2009) Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 30: 2978-2984.
22. Yerebakan C, Kaminski A, Westphal B, Donndorf P, Glass A, et al. (2011) Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant. J Thorac Cardiovasc Surg 142: 1530-1539.
23. Pätilä T, Lehtinen M, Vento A, Schildt J, Sinisalo J, et al. (2014) Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: A prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass. J Heart Lung Transplant pii:S1053-2498(14)00971-1. doi: 10.1016/j.healun.2014.02.009 [Epub ahead of print].
24. Ang KL, Chin D, Leyva F, Foley P, Kubal C, et al. (2008) Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med 5: 663-670.
25. Assmus B, Rolf A, Erbs S, Elsässer A, Haberbosch W, et al. (2010) Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 3: 89-96.
26. Sürder D, Manka R, Lo Cicero V, Moccetti T, Rufibach K, et al. (2013) Intracoronary Injection of Bone Marrow Derived Mononuclear Cells, Early or Late after Acute Myocardial Infarction: Effects on Global Left Ventricular Function Four months results of the SWISS-AMI trial. Circulation 127: 1968-1979.
27. Roncalli J, Mouquet F, Piot C, Trochu JN, Le Corvoisier P, et al. (2011) Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J 32: 1748-1757.
28. Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, van der Giessen WJ, et al. (2011) Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J 32: 1736-1747.
29. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, et al. (2012) Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 308: 2380-2389.
30. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, et al. (2002) Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90: 29-34. (Pubitemid 34671198)
31. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, et al. (2004) Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson 6: 727-765. (Pubitemid 40041279)
32. Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, et al. (2002) Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105: 162-167. (Pubitemid 34084313)
33. Vogel-Claussen J, Rochitte CE, Wu KC, Kamel IR, Foo TK, et al. (2006) Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics 26: 795-810. (Pubitemid 43824977)
34. Nyolczas N1, Charwat S, Posa A, Hemetsberger R, Pavo N, et al. (2009) Tracking the migration of cardially delivered therapeutic stem cells in vivo: state of the art. Regen Med 4: 407-422.